Unusual complex hyperdiploid karyotypes in myelodysplastic syndromes

被引:2
|
作者
Stamatoullas, Aspasia [1 ]
Callat, Marie Paule [1 ]
Marreiros, Sandra [1 ]
Tilly, Herve [1 ]
Bastard, Christian [1 ]
机构
[1] Ctr Henri Becquerel, Grp Etud Proligerat Lympoides, Dept Hematol, INSERM,U614, F-76000 Rouen, France
关键词
D O I
10.1016/j.cancergencyto.2006.05.012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Over an 18-year period, 10 myelodysplastic syndrome (MDS) patients with complex hyperdiploid karyotypes were identified. According to the FAB classification, the 10 patients were subclassified as three refractory anemias (RA), three refractory anemias with excess blasts (RAEB), two RAEB in transformation (RAEB-t), and two unclassified MDS. According to the WHO classification, the diagnoses were two RA, one refractory cytopenia with multilineage dysplasia, two RAEB-1, one RAEB-2, two unclassified NIDS, and two acute myeloid leukemia. Six were secondary NIDS. Four patients showed marked dyserythropoiesis; three of these were secondary NIDS. The chromosome number ranged from 47 to 62, and clonal evolution or composite karyotypes were noted in 7 patients. Seven patients had at least one clone with > 50 chromosomes. Recurrent defects included chromosome 5, 17, and 13 abnormalities. Notably, trisomy 8 and monosomy 7 were rare in that group of patients. Three of four patients with marked dyserythropoiesis shared abnormalities of both chromosomes 13 and 17. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:129 / 132
页数:4
相关论文
共 50 条
  • [1] Prognostic impact of hyperdiploid karyotypes including isolated trisomies in patients with myelodysplastic syndromes
    Strapatsas, J.
    Kreft, A. -L
    Hildebrandt, B.
    Kasprzak, A.
    Haase, D.
    Aul, C.
    Pfeilstocker, M.
    Valent, P.
    Blum, S.
    Machherndl-Spandl, S.
    Luebbert, M.
    Goetze, K.
    Stauder, R.
    Haas, R.
    Germing, U.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 99 - 100
  • [2] Clonal Heterogeneity in Patients with Myelodysplastic Syndromes (MDS) and Complex Karyotypes
    Zemanova, Zuzana
    Michalova, Kyra
    Brezinova, Jana
    Lhotska, Halka
    Svobodova, Karla
    Sarova, Iveta
    Lizcova, Libuse
    Izakova, Silvia
    Ransdorfova, Sarka
    Krejcik, Zdenek
    Belickova, Monika
    Siskova, Magda
    Jonasova, Anna
    Neuwirtova, Radana
    Zmolikova, Jana
    Cermak, Jaroslav
    BLOOD, 2014, 124 (21)
  • [3] Genomic imbalances in 139 patients with myelodysplastic syndromes (MDS) and complex karyotypes
    Zemanova, Zuzana
    Michalova, Kyra
    Brezinova, Jana
    Buryova, Halka
    Kostylkova, Karla
    Bystricka, Dagmar
    Novakova, Milena
    Sarova, Iveta
    Izakova, Silvia
    Lizcova, Libuse
    Ransdorfova, Sarka
    Zmolikova, Jana
    Siskova, Magda
    Cermak, Jaroslav
    CHROMOSOME RESEARCH, 2013, 21 : S92 - S93
  • [4] Cytogenetic profile of myelodysplastic syndromes with complex karyotypes:: an analysis using spectral karyotyping
    Martínez-Ramírez, A
    Urioste, M
    Alvarez, S
    Vizmanos, JL
    Calasanz, MJ
    Cigudosa, JC
    Benítez, J
    CANCER GENETICS AND CYTOGENETICS, 2004, 153 (01) : 39 - 47
  • [5] Molecular cytogenetic profiling of complex karyotypes in primary myelodysplastic syndromes and acute myeloid leukemia
    Trost, D
    Hildebrandt, B
    Beier, M
    Müller, N
    Germing, U
    Royer-Pokora, B
    CANCER GENETICS AND CYTOGENETICS, 2006, 165 (01) : 51 - 63
  • [6] Array comparative genomic hybridization analysis of myelodysplastic syndromes with complex karyotypes.: A technical evaluation
    Martínez-Ramírez, A
    Urioste, M
    Calasanz, MJ
    Cigudosa, JC
    Benítez, J
    CANCER GENETICS AND CYTOGENETICS, 2003, 144 (01) : 87 - 89
  • [7] TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups
    Haase, Detlef
    Stevenson, Kristen E.
    Neuberg, Donna
    Maciejewski, Jaroslaw P.
    Nazha, Aziz
    Sekeres, Mikkael A.
    Ebert, Benjamin L.
    Garcia-Manero, Guillermo
    Haferlach, Claudia
    Haferlach, Torsten
    Kern, Wolfgang
    Ogawa, Seishi
    Nagata, Yasunobu
    Yoshida, Kenichi
    Graubert, Timothy A.
    Walter, Matthew J.
    List, Alan F.
    Komrokji, Rami S.
    Padron, Eric
    Sallman, David
    Papaemmanuil, Elli
    Campbell, Peter J.
    Savona, Michael R.
    Seegmiller, Adam
    Ades, Lionel
    Fenaux, Pierre
    Shih, Lee-Yung
    Bowen, David
    Groves, Michael J.
    Tauro, Sudhir
    Fontenay, Michaela
    Kosmider, Olivier
    Bar-Natan, Michal
    Steensma, David
    Stone, Richard
    Heuser, Michael
    Thol, Felicitas
    Cazzola, Mario
    Malcovati, Luca
    Karsan, Aly
    Ganster, Christina
    Hellstrom-Lindberg, Eva
    Boultwood, Jacqueline
    Pellagatti, Andrea
    Santini, Valeria
    Quek, Lynn
    Vyas, Paresh
    Tuechler, Heinz
    Greenberg, Peter L.
    Bejar, Rafael
    LEUKEMIA, 2019, 33 (07) : 1747 - 1758
  • [8] TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups
    Detlef Haase
    Kristen E. Stevenson
    Donna Neuberg
    Jaroslaw P. Maciejewski
    Aziz Nazha
    Mikkael A. Sekeres
    Benjamin L. Ebert
    Guillermo Garcia-Manero
    Claudia Haferlach
    Torsten Haferlach
    Wolfgang Kern
    Seishi Ogawa
    Yasunobu Nagata
    Kenichi Yoshida
    Timothy A. Graubert
    Matthew J. Walter
    Alan F. List
    Rami S. Komrokji
    Eric Padron
    David Sallman
    Elli Papaemmanuil
    Peter J. Campbell
    Michael R. Savona
    Adam Seegmiller
    Lionel Adès
    Pierre Fenaux
    Lee-Yung Shih
    David Bowen
    Michael J. Groves
    Sudhir Tauro
    Michaela Fontenay
    Olivier Kosmider
    Michal Bar-Natan
    David Steensma
    Richard Stone
    Michael Heuser
    Felicitas Thol
    Mario Cazzola
    Luca Malcovati
    Aly Karsan
    Christina Ganster
    Eva Hellström-Lindberg
    Jacqueline Boultwood
    Andrea Pellagatti
    Valeria Santini
    Lynn Quek
    Paresh Vyas
    Heinz Tüchler
    Peter L. Greenberg
    Rafael Bejar
    Leukemia, 2019, 33 : 1747 - 1758
  • [9] Mutation Profiles of TP53 and PPM1D in Patients with Myelodysplastic Syndromes and complex Karyotypes
    Eder, Lea Naomi
    Ganster, Christina
    Shirneshan, Katayoon
    Rittscher, Katharina
    Schaab, Roxana
    Martin, Roman
    Dierks, Sascha
    Haase, Detlef
    INTERNIST, 2020, 61 (SUPPL 1): : S41 - S41
  • [10] CHROMOTHRIPSIS IN BONE MARROW CELLS OF ADULT PATIENTS WITH NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROMES (MDS) WITH COMPLEX KARYOTYPES.
    Zemanova, Z.
    Lhotska, H.
    Brezinova, J.
    Lizcova, L.
    Svobodova, K.
    Sarova, I.
    Izakova, S.
    Ransdorfova, S.
    Krejcik, Z.
    Dostalova, M.
    Siskova, M.
    Jonasova, A.
    Neuwirtova, R.
    Cermak, J.
    Michalova, K.
    HAEMATOLOGICA, 2014, 99 : 82 - 82